Form 4: Agilent Technologies Executive Padraig McDonnell Reports Stock and Option Grants

Senior Vice President Padraig McDonnell reports the acquisition of restricted stock units and stock options in Agilent Technologies.

Summary

• Padraig McDonnell, a Senior Vice President at Agilent Technologies, reported a transaction on March 1, 2024.
• McDonnell acquired 3,202 shares of common stock at a price of $139.06.
• These shares were granted as Restricted Stock Units (RSUs) under the company's 2018 Stock Plan.
• The RSUs vest in four equal annual installments starting March 1, 2025, and are subject to a 1-year post-vest holding period.
• McDonnell also acquired an option to buy 9,076 shares of Agilent Technologies common stock at an exercise price of $139.06.
• This option also vests in four equal annual installments beginning on March 1, 2025, and expires on March 1, 2034.
• Following the reported transaction, McDonnell beneficially owns 27,317 shares of Agilent Technologies common stock directly.
• McDonnell also directly owns options for 9,076 shares.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and incentivized management structure. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs and stock options to a senior executive suggests the company is incentivizing leadership to drive future performance.
• The vesting schedules for both the RSUs and stock options align executive interests with long-term shareholder value.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of the RSUs and stock options suggest a multi-year horizon for incentivizing executive performance.

Industry Context

Executive compensation through stock grants and options is a common practice in the technology industry to align management interests with shareholder value and incentivize long-term growth.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation practices among Agilent's peers in the scientific instrument and life sciences industries.
• Companies like Thermo Fisher Scientific, Danaher, and PerkinElmer also utilize similar equity-based compensation plans to attract and retain top talent.
• The vesting schedules and grant sizes are likely benchmarked against industry averages to ensure competitiveness.

Stakeholder Impact

• Shareholders: The grants align executive interests with shareholder value.
• Employees: The grants may have a positive impact on employee morale as they see executives being rewarded for performance.

Key Dates